Literature DB >> 12601442

Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery.

François Dagenais1, Patrick Mathieu.   

Abstract

Severe unresponsive vasoplegia syndrome following cardiopulmonary bypass is rare. The authors report a case of severe vasoplegia, unresponsive to conventional treatment three days following cardiopulmonary bypass. A single intravenous bolus (2 mg/kg) of methylene blue was administered with normalization of the peripheral resistance. The use of methylene blue as rescue therapy in severe vasoplegia syndrome is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601442

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  Anaphylaxis with Latrodectus antivenin resulting in cardiac arrest.

Authors:  Christine M Murphy; Jeannie J Hong; Michael C Beuhler
Journal:  J Med Toxicol       Date:  2011-12

2.  Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.

Authors:  J Hunter Mehaffey; Lily E Johnston; Robert B Hawkins; Eric J Charles; Leora Yarboro; John A Kern; Gorav Ailawadi; Irving L Kron; Ravi K Ghanta
Journal:  Ann Thorac Surg       Date:  2017-05-24       Impact factor: 4.330

3.  Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review.

Authors:  Seyed Mohsen Mirhosseini; Ali Sanjari Moghaddam; Paritash Tahmaseb Pour; Ali Dabbagh
Journal:  J Tehran Heart Cent       Date:  2017-01

4.  The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.

Authors:  Walter Petermichl; Michael Gruber; Ina Schoeller; Kwahle Allouch; Bernhard M Graf; York A Zausig
Journal:  J Cardiothorac Surg       Date:  2021-07-28       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.